Table 3 Summary results of peripheral BDNF levels in persons with ASD and healthy controls.

From: Peripheral brain-derived neurotrophic factor in autism spectrum disorder: a systematic review and meta-analysis

Variables

No. of comparisions

No. of subjects

Meta-analysis

Heterogeneity

Test for subgroup differences

ASD

Controls

SMD

95% CI

P-value

I2

P-value

I2

P-value

Biomaterial

 Serum

13

985

1526

0.58

0.11

1.04

0.02

96

<0.001

81.6

0.02

 Plasma

1

146

50

1.27

0.92

1.61

<0.001

Not applicable

Not applicable

  

Condition

 ASD

5

538

974

0.64

0.1

1.19

0.02

92

<0.001

0

0.82

 autism

9

593

602

0.55

−0.03

1.13

0.06

94

<0.001

  

Subject age

 Childhood

10

1010

1295

0.78

0.31

1.26

0.001

96

<0.001

0

0.42

 Adulthood

4

121

281

0.04

−1.72

1.8

0.97

97

<0.001

  

Analytical technology

 ELISA

11

619

622

0.66

0.12

1.2

0.02

94

<0.001

96.6

<0.001

 Luminex

3

470

920

−0.03

−0.14

0.08

0.56

0

0.84

  

 RIAC

1

69

54

1.57

1.16

1.98

<0.001

Not applicable

Not applicable

  

Subject age & analytical technology

Childhood

 ELISA

7

498

341

0.93

0.54

1.33

<0.001

85

<0.001

97.2

<0.001

 Luminex

3

470

920

−0.03

−0.14

0.08

0.56

0

0.84

  

 RIAC

1

69

54

1.57

1.16

1.98

<0.001

Not applicable

Not applicable

  

Adulthood

 ELISA

4

121

281

0.04

−1.72

1.8

0.97

97

<0.001

Not applicable

Not applicable

  1. ASD: autism spectrum disorder; No.: number; CI: confidence interval; RIAC: recycling immunoaffinity chromatography; ELISA: enzyme-linked immunosorbent assay.